FYI. The following info is being forwarded for those who have an interest in
the link between environmental toxins and parkinson's disease, including the
possible role of hormone (im)balances on the disease and/or its symptoms
(e.g., a woman's PD symptoms temporarily worsen just before her period
typically). I know there's research ongoing into the link between estrogen
and alzheimer's since more women than men get it. Since PD is similar to AD,
and many pesticides are estrogenating compounds, I figure this might be
relevant, should anyone be interested in attending:
****************************
---------------------
Forwarded message:
From: [log in to unmask] (everybody)
Sender: [log in to unmask]
Reply-to: [log in to unmask]
To: [log in to unmask] (Multiple recipients of list)
Date: 96-05-15 13:57:05 EDT
[Federal Register: May 8, 1996 (Volume 61, Number 90)]
[Notices]
[Page 20814-20815]
>From the Federal Register Online via GPO Access [wais.access.gpo.gov]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[OPP-00436; FRL-5369-8]
Endocrine Disruption by Chemicals: Next Steps in Chemical
Screening and Testing; Open Meeting
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice of open meeting.
-----------------------------------------------------------------------
SUMMARY: Recent research indicates that environmental endocrine
disruptors need more attention by chemical and pesticide regulators.
The EPA will hold a meeting on May 15 and May 16, 1996 in the
Washington, DC metropolitan area to discuss how EPA can work
cooperatively with industry, the environmental community, academia and
others to develop a screening and
[[Page 20815]]
testing strategy to identify chemicals that may pose significant risks
through endocrine disruption. This notice announces the location and
times for the meeting and sets forth tentative agenda topics. EPA has
invited 20 representatives of industry, the environmental community,
academia, and government to this meeting. The meeting is open to the
public, but space for observers is limited. The meeting is structured
to allow the invited participants to discuss items on a predetermined
agenda. However, at the end of the first day, there will be thirty
minutes of open discussion.
DATES: The meeting will be held from 2 p.m. to 6 p.m. on May 15, 1996,
and 8:30 a.m. to 12:00 p.m. on May 16, 1996.
ADDRESSES: The meeting will be held at the Sheraton Crystal City Hotel,
1800 Jefferson Davis Highway, Arlington, Virginia 22202. A meeting room
will be announced in the hotel.
FOR FURTHER INFORMATION CONTACT: Observers can register by calling
Donald Walker, TASCON Corporation, at (301) 907-3844, ext. 251. To
obtain general information about the meeting, contact Sheryl K. Reilly,
Office of Pesticide Programs, Environmental Protection Agency, by phone
(703) 308-4774. Persons who cannot attend the meeting, but wish to
comment, should send comments to Sheryl K. Reilly, Office of Pesticide
Programs (7501C), Environmental Protection Agency, 401 M St., SW.,
Washington, DC 20460. Office Location: Rm. 1119, Crystal Mall #2, 1921
Jefferson Davis Highway, Arlington, VA; e-mail:
[log in to unmask]
SUPPLEMENTARY INFORMATION: As an indication of the public's concern
about endocrine disruptors, the Senate recently passed a bill by a vote
of 99 to 1 that would amend the Safe Drinking Water Act to require EPA
to initiate a screening and testing program for environmental estrogens
within two years of its effective date, with discretionary authority to
expand this effort to other kinds of endocrine disruptors. Although EPA
has recently proposed new test guidelines for reproductive and
developmental toxicity, subjecting all 600 pesticides and 80,000
existing chemicals would be an enormous challenge. How to develop a
screening and testing program for environmental estrogens and other
hormone-like substances is the focus of this meeting. EPA expects that
approximately twenty invited representatives from various organizations
will participate in the two-day program. Ongoing activities to address
endocrine disruption at the EPA will be reviewed, and key issues,
identified by the invited participants, will be discussed. EPA's
objective in convening this meeting is to obtain the input of key
stakeholders on the prospect of forming a multi-stakeholder scientific/
technical taskforce to develop a chemical screening and testing
strategy.
The tentative agenda of the meeting includes the following:
1. Overview of EPA's Office of Research and Development (ORD)
activities related to endocrine disruptors and discussion of the draft
ORD research strategy.
2. Identification and discussion of key issues.
a. How should we begin the development of a screening and
testing strategy?
b. What would be the objectives of the screening and testing
strategy?
c. Should we focus initially on the reproductive hormone system?
d. What role should structure-activity/SAR-like screens play?
3. Discussion of the taskforce concept.
List of Subjects
Environmental protection.
Dated: May 3, 1996.
Lynn R. Goldman,
Assistant Administrator, Office of Prevention, Pesticides, and Toxic
Substances.
[FR Doc. 96-11616 Filed 5-7-96; 8:45 am]
BILLING CODE 6560-50-F
